期刊文献+

塞来昔布抑制骨肉瘤细胞黏附侵袭及其机制 被引量:3

Inhibitory effects of celecoxib on adhesion and invasion of osteosarcoma cell lines and the mechanisms
原文传递
导出
摘要 目的 观察环氧合酶2(COX-2)抑制剂塞来昔布对骨肉瘤MG-63和U2-OS细胞增殖、黏附和侵袭的抑制作用,探讨其分子机制.方法 采用噻唑蓝(MTF)比色法、黏附实验、侵袭实验、流式细胞术和Western blot研究25、50、100 μmol/L 3种浓度塞来昔布对两种细胞株增殖、黏附、侵袭能力及CD44和基质金属酶(MMP)-9表达的影响.结果 3种浓度的塞来昔布作用48 h后MG-63细胞增殖抑制率分别为9.35%、42.68%、60.29%(P<0.05),对U2-OS细胞的抑制率分别为2.59%、8.95%、29.36%(P<0.05).对MG-63的黏附抑制率分别为8.6%、21. 5%、52.8%(P<0.05) 对U2-OS的黏附抑制率分别为1.6%、3.8%、19.0%(P<0.05) 对两种骨肉瘤细胞的侵袭能力、CD44和MMP-9的表达均有抑制作用,对高表达COX-2的MG-63的抑制效应更加显著.结论 塞来昔布可抑制骨肉瘤细胞的增殖、黏附和侵袭,这种作用与下调CD44和MMP-9的表达有关,此种效应具有COX-2依耐性. Objective To evaluate the effects of cyclooxygenase-2 (COX-2) inhibitor Celecoxib on the proliferation, adhesion and invasion of MG-63 and U2-OS osteosarcoma cell lines, and explore the molecular mechanisms. Methods Methyl thiazol tetrazolium (MTT) assay, adhesive assay and Transwell chamber in vitro invasion assay were employed to examine the change of the proliferation, adhesion and invasion ability of the cell lines which treated by different concentrations (25, 50, 100 μmol/L) of celecoxib for 24 h.Flow cytometry and Western blotting were used to detect the change of CD44 and matrix metalloproteinase (MMP)-9 expression after the treatment. Results The proliferation inhibition rate of the three concentrations of celecoxib on MG-63 cell line was 9. 35%, 42. 68%, 60. 29% (P 〈0. 05) respectively, on U2-0S cell line was 2. 59%, 8. 95%, 29. 36% (P 〈0. 05) respectively the adhesive inhibition rate on MG-63 cell line was 8.6%, 21.5%, 52.8% (P〈0.05) respectively, on U2-OS was 1.6%, 3.8%, 19.0% (P〈0. 05) respectively. The invasion ability and the expression of CD44 and MMP-9 in MG-63 and U2-OS cells were inhibited by celecoxib, but the inhibition effect was more obvious in MG-63 which expressed higher COX-2. Conclusion The selective COX-2 inhibitor celecoxib can inhibit the proliferation, adhesion and invasion of human osteosarcoma cell lines through downregulating the level of CD44 and MMP-9, which was COX-2-dependent.
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2010年第11期1648-1650,共3页 Chinese Journal of Experimental Surgery
基金 甘肃省自然科学基金资助项目(0803RJZA076)
关键词 骨肉瘤 环氧合酶抑制剂 CD44 金属蛋白酶 Osteosarcoma Inhibitor of COX-2 CD44 Metalloproteinase
  • 相关文献

同被引文献16

  • 1Storr S J,Carragher NO,Frame MC,et al.The calpain system and cancer[J].Nat Rev Cancer,2011,11 (5):364-374.
  • 2Fan DG,Dai JY,Tang J,et al.Silencing of calpain expression reduces the metastatic potential of human osteosarcoma cells[J].Cell Biol Int,2009,33 (12):1263-1267.
  • 3Li SZ,Zhang HH,Zhang JN,et al.ALLN hinders HCT116 tumor growth through Bax-dependent apoptosis[J].Biochem Biophys Res Commun,2013,437 (2):325-330.
  • 4Demarchi F,Bertoli C,Greer PA,et al.Ceramide triggers an NF-kappaB-dependent survival pathway through calpain[J].Cell Death Differ,2005,12 (5):512-522.
  • 5Mamoune A,Luo JH,Lauffenburger DA,et al.Calpain-2 as a target for limiting prostate cancer invasion[J].Cancer Res,2003,63 (15):4632-4640.
  • 6Li C,Chen S,Yue P,et al.Proteasome inhibitor PS-341 (bortezomib) induces calpain-dependent IkappaB (alpha) degradation[J].J Biol Chem,2010,285 (21):16096-16104.
  • 7Mlynarczuk-Bialy I,Roeckmann H,Kuckelkom U,et al.Combined effect of proteasome and calpain inhibition on cisplatin-resistant human melanoma cells[J].Cancer Res,2006,66 (15):7598-7605.
  • 8Liu TL,Shimada H,Ochiai T,et al.Enhancement of chemosensitivity toward peplomycin by calpastatin-stabilized NF-kappaB p65 in esophageal carcinoma cells:possible involvement of Fas/Fas-L synergism[J].Apoptosis,2006,11 (6):1025-1037.
  • 9Okami J,Naaanofi S,Hiraoka N. Suppression of pancreatic cancer cell I nvasion by a cyclooxygenase-2-specific inhibitor[J].Clinical and Experimental Metastasis,2003.577-584.
  • 10Sahin M,Sahin E,Gümüslü S. Cyelooxygenase-2 in cancer and angiogenesis[J].Angiology,2009.242-253.

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部